Jennifer Plichta, MD, MS, FACS from the Duke Cancer Institute, will be our next breast cancer focus group series speaker on Tuesday April 15, 2025, from 4:00-5:00PM.

Her presentation is titled, "Prognostic Staging for de novo Metastatic Breast Cancer: The past, present, and future.”

We are truly honored to have Dr. Plichta share her expertise with us, and we look forward to an engaging and enlightening discussion.

Attendants are eligible to receive 1 hour of CME: 1.0 AMA PRA Category 1 Credit^TM for physicians or 1.0 ANCC Contact Hours for nurses.

Learning Objectives: 

1. Describe the variability in survival outcomes for patients with dnMBC

2. Explain how the variability may impact treatment approach